Scholar Alert: [ intitle:laryngeal ]
miR-217 inhibits laryngeal cancer metastasis by repressing AEG-1 and PD-L1 expression.
S Miao, X Mao, S Zhao, K Song, C Xiang, Y Lv, H Jiang… - Oncotarget, 2017
High incidences of laryngeal cancer have been reported recently. Increasing our
understanding of the molecular mechanisms underlying this malignancy could reveal more
effective approaches to treating laryngeal cancer patients and so improve their prognoses.
understanding of the molecular mechanisms underlying this malignancy could reveal more
effective approaches to treating laryngeal cancer patients and so improve their prognoses.
Analysis of Association Between MGMT and p53 Gene Single Nucleotide Polymorphisms and Laryngeal Cancer
Y LV, C JIA, A JIANG, HUA ZHANG, Y WANG, F LIU… - Anticancer Research, 2017
Aim: To investigate the p53 and O 6-methylguanine DNA methyltransferase (MGMT)
5'upstream sequence gene promoter regions for single nucleotide polymorphisms and
explore the p53 gene 5'upstream sequence consisting of two haplotypes to provide a
5'upstream sequence gene promoter regions for single nucleotide polymorphisms and
explore the p53 gene 5'upstream sequence consisting of two haplotypes to provide a
Application of Ultrasound-guided Core Needle Biopsy in the Diagnosis of T3 or T4 Stage Laryngeal and Hypopharyngeal Cancer
Y WANG, D LI, R LIU, C JIA, A JIANG, Y LV, S XU… - Anticancer Research, 2017
Aim: To study the value of ultrasound-guided core needle biopsy (CNB) in the diagnosis of
T3 or T4 stage laryngeal and hypopharyngeal cancer, which is difficult by routine methods.
Patients and Methods: Nineteen cases of T3 or T4 stage laryngeal or hypopharyngeal
T3 or T4 stage laryngeal and hypopharyngeal cancer, which is difficult by routine methods.
Patients and Methods: Nineteen cases of T3 or T4 stage laryngeal or hypopharyngeal
Cyclooxygenase-2 Inhibition Enhances Proliferation of NKT Cells Derived from Patients with Laryngeal Cancer
J KLATKA, E GRYWALSKA, A HYMOS, M GUZ… - Anticancer Research, 2017
Background/Aim: The aim of this study was to analyze whether inhibition of cyclooxygenase-
2 by celecoxib and the subsequent enhancement in the proliferation of natural killer T (NKT)
cells could play a role in dendritic cell (DC)-based laryngeal cancer (LC) immunotherapy.
2 by celecoxib and the subsequent enhancement in the proliferation of natural killer T (NKT)
cells could play a role in dendritic cell (DC)-based laryngeal cancer (LC) immunotherapy.
This Google Scholar Alert is brought to you by Google.
Cancel alert
List my alerts
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου